Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Firebrick Pharma Limited ( (AU:FRE) ).
Firebrick Pharma Limited has announced its Annual General Meeting (AGM) will be held virtually on November 26, 2025, allowing shareholders to participate online. The company has set October 8, 2025, as the deadline for director nominations, which must be submitted in writing to their registered office. This meeting is a significant event for stakeholders as it provides an opportunity to discuss the company’s strategic direction and governance.
More about Firebrick Pharma Limited
Firebrick Pharma is a pharmaceutical innovator specializing in the development and commercialization of novel formulations and uses of povidone-iodine (PVP-I). The company has launched its Nasodine Nasal Spray in the United States, Singapore, and Fiji & South Pacific, with plans to enter the Philippine market in 2026.
Average Trading Volume: 84,129
Technical Sentiment Signal: Sell
Learn more about FRE stock on TipRanks’ Stock Analysis page.